IRIS UniCatt

Montuschi, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.826
AS - Asia 3.625
EU - Europa 3.000
SA - Sud America 763
Continente sconosciuto - Info sul continente non disponibili 180
AF - Africa 97
OC - Oceania 18
Totale 12.509
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.681
SG - Singapore 1.625
CN - Cina 803
DE - Germania 625
BR - Brasile 591
SE - Svezia 566
IT - Italia 429
VN - Vietnam 415
UA - Ucraina 272
FR - Francia 227
IE - Irlanda 178
GB - Regno Unito 162
HK - Hong Kong 121
ID - Indonesia 119
IN - India 116
PL - Polonia 114
FI - Finlandia 113
BD - Bangladesh 79
TR - Turchia 76
RU - Federazione Russa 72
CA - Canada 67
AR - Argentina 60
NL - Olanda 57
JP - Giappone 53
MX - Messico 41
ZA - Sudafrica 34
AT - Austria 33
BE - Belgio 33
IQ - Iraq 33
EC - Ecuador 27
ES - Italia 26
KR - Corea 24
PK - Pakistan 22
CL - Cile 21
CO - Colombia 21
SA - Arabia Saudita 21
AU - Australia 16
MA - Marocco 16
IR - Iran 15
CH - Svizzera 14
VE - Venezuela 12
EG - Egitto 11
IL - Israele 11
LT - Lituania 10
UZ - Uzbekistan 10
AZ - Azerbaigian 9
PH - Filippine 9
JO - Giordania 8
KE - Kenya 8
PE - Perù 8
PY - Paraguay 8
UY - Uruguay 8
AL - Albania 7
BG - Bulgaria 7
CZ - Repubblica Ceca 7
DZ - Algeria 6
JM - Giamaica 6
MY - Malesia 6
NP - Nepal 6
PT - Portogallo 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
KZ - Kazakistan 5
OM - Oman 5
PA - Panama 5
RS - Serbia 5
BA - Bosnia-Erzegovina 4
BO - Bolivia 4
CR - Costa Rica 4
EU - Europa 4
KG - Kirghizistan 4
LV - Lettonia 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
DK - Danimarca 3
DO - Repubblica Dominicana 3
EE - Estonia 3
ET - Etiopia 3
GR - Grecia 3
HN - Honduras 3
HR - Croazia 3
HU - Ungheria 3
IS - Islanda 3
LB - Libano 3
LU - Lussemburgo 3
NI - Nicaragua 3
AO - Angola 2
BH - Bahrain 2
CI - Costa d'Avorio 2
GE - Georgia 2
IM - Isola di Man 2
KH - Cambogia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
YE - Yemen 2
AG - Antigua e Barbuda 1
Totale 12.307
Salva come PNG Salva come JPEG
Città #
Singapore 861
Ashburn 593
Chandler 491
San Jose 390
Dublin 173
Beijing 168
San Mateo 147
Ho Chi Minh City 125
Los Angeles 123
Jacksonville 122
New York 115
Cattolica 114
Hanoi 113
Nanjing 110
Warsaw 110
Jakarta 102
Ann Arbor 101
Hong Kong 98
Lauterbourg 90
Bremen 87
Wilmington 85
Boston 76
The Dalles 76
Woodbridge 75
Munich 66
Fairfield 59
Lawrence 55
Redwood City 55
Hefei 54
Milan 53
Frankfurt am Main 52
Moscow 51
Dallas 50
Rome 50
Izmir 46
São Paulo 45
Tokyo 45
Buffalo 44
Dearborn 43
Seattle 43
Houston 42
Boardman 37
Santa Clara 37
Princeton 33
Helsinki 32
Brussels 29
Shanghai 28
Chicago 27
Guangzhou 27
Hangzhou 26
Orem 25
Rio de Janeiro 25
Vienna 23
Paris 22
Nanchang 21
Atlanta 20
Brooklyn 20
Da Nang 20
Kent 20
Nürnberg 20
Wageningen 20
Cambridge 19
Marseille 19
Montreal 19
Norwalk 19
Columbus 18
Dhaka 18
Johannesburg 18
Mountain View 18
London 17
Redmond 17
Denver 16
San Francisco 16
Toronto 16
Manchester 15
Nuremberg 15
Shenyang 15
Chennai 14
Fremont 14
Hebei 14
Mexico City 14
Miami 14
Seoul 14
Tianjin 14
Council Bluffs 13
Pune 13
Stockholm 13
Clifton 12
Porto Alegre 12
Turku 12
Zhengzhou 12
Amsterdam 11
Baghdad 11
Changsha 11
Falls Church 11
Jiaxing 11
Lancaster 11
Phoenix 11
Biên Hòa 10
Bogotá 10
Totale 6.467
Salva come PNG Salva come JPEG
Nome #
Breathomics for Assessing the Effects of Treatment and Withdrawal With Inhaled Beclomethasone/Formoterol in Patients With COPD 349
Development of a sensing array for human breath analysis based on SWCNT layers functionalized with semiconductor organic molecules 249
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 242
Computed tomography for evaluation of the small airway disease in asthma. 226
Urinary Leukotriene E4 and Prostaglandin D2 Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type 2 Inflammation. A Clinical Observational Study 222
Detection and characterization of extracellular vesicles in exhaled breath condensate and sputum of COPD and severe asthma patients 211
Impact of air pollution on respiratory diseases in urban areas: a systematic review 206
Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease 194
Within-day and between-day repeatability of measurements with an electronic nose in patients with COPD 188
Electronic nose and exhaled breath NMR-based metabolomics applications in airways disease 185
Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease 184
Electronic nose and exhaled breath NMR-based metabolomics applications in airways disease 182
Development of a Sensing Array for Human Breath Analysis Based on SWCNT Layers Functionalized with Semiconductor Organic Molecules 182
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life 180
Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry 177
Metabolomic analysis of exhaled breath condensate in patients with asthma and COPD 171
Liquid chromatography-mass spectrometry measurement of leukotrienes in asthma and other respiratory diseases 170
Investigational prostaglandin D2 receptor antagonists for airway inflammation 170
U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics 170
Inhaled muscarinic acethylcholine receptor antagonists for treatment of COPD 167
NMR-Based Metabolomics for the Assessment of Inhaled Pharmacotherapy in Chronic Obstructive Pulmonary Disease Patients 167
Exploring the performance of a functionalized CNT-based sensor array for breathomics through clustering and classification algorithms: From gas sensing of selective biomarkers to discrimination of chronic obstructive pulmonary disease 167
Dupilumab for the treatment of asthma 155
Non-invasive biomarkers of lung inflammation in smoking subjects 149
NMR spectroscopy-based metabolomics of exhaled breath condensate in inflammatory respiratory diseases 148
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) 144
Leukotriene modifiers for asthma treatment 139
Exhaled Nitric Oxide Measurement in Patients Affected by Nasal Polyposis 139
Gallbladder emptying, plasma levels of estradiol and progesterone, and cholecystokinin secretion in liver cirrhosis 138
Impulse oscillometry and nitrogen washout test in the assessment of small airway dysfunction in asthma: correlation with quantitative computed tomography 138
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 135
Stratification of asthma phenotypes by airway proteomic signatures 134
Severe asthma: One disease and multiple definitions 134
Liquid chromatography/mass spectrometry analysis of exhaled leukotriene B4 in asthmatic children 129
Pharmacotherapy of asthma: regular treatment or on demand? 129
8-isoprostane in exhaled breath condensate after experimental exposure to wood smoke in humans 128
Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort 124
Comparison of classification methods in breath analysis by electronic nose 123
Indirect monitoring of lung inflammation 121
Dupilumab for the treatment of asthma 121
Predictive markers of bronchial hyperreactivity in a large cohort of young adults With cough variant asthma 121
Novel perspectives in the detection of oral and nasal oxidative stress and inflammation in pediatric united airway diseases 120
Bronchodilating drugs for chronic obstructive pulmonary disease: current status and future trends 119
Single-inhaler triple therapy utilizing the once-daily combination of fluticasone furoate, umeclidinium and vilanterol in the management of COPD: the current evidence base and future prospects 117
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 117
Immediate allergic reactions to beta-lactams: diagnosis and therapy. 115
The combined impact of exhaled nitric oxide and sputum eosinophils monitoring in asthma treatment: a prospective cohort study 110
LC/MS/MS analysis of leukotriene B4 in exhaled breath condensate for assessing lung inflammation. 108
IL-17-high asthma with features of a psoriasis immunophenotype 108
Medication Adherence in Patients With Severe Asthma Prescribed Oral Corticosteroids in the U-BIOPRED Cohort 105
Exhaled breath condensate in COPD: application in clinical practice 105
Diagnostic performance of an electronic nose, fractional exhaled nitric oxide, and lung function testing in asthma. 105
Comparison of two exhaled biomarkers in children with and without sleep disordered breathing 105
Role of beta-blockers in patients with COPD: current perspective 104
8-Isoprostane in exhaled breath condensate and exercise-induced bronchoconstriction in asthmatic children and adolescents. 101
Long-acting beta-agonists and their association with inhaled corticosteroids in COPD 101
New perspectives in pharmacological treatment of mild persistent asthma 100
The discovery and development of aclidinium bromide for the treatment of chronic obstructive pulmonary disease 100
Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study 99
Treatable traits in the European U-BIOPRED adult asthma cohorts 99
Triple inhaled therapy for chronic obstructive pulmonary disease 98
Metabolomic analysis by nuclear magnetic resonance spectroscopy as a new approach to understanding inflammation and monitoring of pharmacological therapy in children and young adults with cystic fibrosis 98
Pharmacotherapy of patients with mild persistent asthma: strategies and unresolved issues 97
eNose breath prints as a surrogate biomarker for classifying patients with asthma by atopy 95
WHITIN-DAY AND BETWEEN-DAY REPEATIBILITY OF MEASURERMENTS WITH AN ELECTRONIC NOSE IN PATIENTS WITH COPD 95
The electronic nose in respiratory medicine. 94
Application of 'omics technologies to biomarker discovery in inflammatory lung diseases. 94
Within-day and between-day repeatability of measurements with an electronic nose in patients with COPD 93
Identification and prospective stability of electronic nose (eNose)-derived inflammatory phenotypes in patients with severe asthma 93
Exhaled nitric oxide as a biomarker in COPD and related comorbidities 92
Methodological considerations for large-scale breath analysis studies: lessons from the U-BIOPRED severe asthma project 92
Exhaled volatile organic compounds as markers for medication use in asthma 92
High sputum total adiponectin is associated with low odds for asthma. 91
Exhaled breath condensate biomarkers of airway inflammation and oxidative stress in COPD 89
Drugs for chronic obstructive pulmonary disease. 89
Nuclear magnetic resonance-based metabolomics discriminates primary ciliary dyskinesia from cystic fibrosis 89
Lipid phenotyping of lung epithelial lining fluid in healthy human volunteers 89
NMR spectroscopy metabolomic profiling of exhaled breath condensate in patients with stable and unstable cystic fibrosis 88
The role of inflammation in anxiety and depression in the European U-BIOPRED asthma cohorts 86
Nuclear magnetic resonance-based metabolomics of exhaled breath condensate: methodological aspects 86
The potential role of endothelial dysfunction and platelet activation in the development of thrombotic risk in COPD patients 86
Transcriptional regulation of kinases downstream of the T cell receptor: another immunomodulatory mechanism of glucocorticoids 85
Pharmacological treatment of chronic obstructive pulmonary disease: from evidence-based medicine to phenotyping 84
Sputum proteomic signature of gastro-oesophageal reflux in patients with severe asthma 84
Separating Smoking-Related Diseases Using NMR-Based Metabolomics of Exhaled Breath Condensate 83
Role of beta-blockers in patients with COPD: current perspective 82
Editorial: Insights in respiratory pharmacology: 2021 81
Exhaled 8-isoprostane and prostaglandin E2 in patients with stable and unstable cystic fibrosis. 81
Characteristics and treatment regimens across ERS SHARP severe asthma registries 81
Mapping atopic dermatitis and anti-IL-22 response signatures to type 2-low severe neutrophilic asthma 81
A European Respiratory Society technical standard: exhaled biomarkers in lung disease 80
Exhaled breath condensate, nasal eosinophil cationic protein level and nasal cytology during immunotherapy for cypress allergy. 76
Large-Scale Label-Free Quantitative Mapping of the Sputum Proteome 76
Vilanterol trifenatate for the treatment of COPD 74
Enhanced oxidative stress in smoking and ex-smoking severe asthma in the U-BIOPRED cohort 68
Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux 68
Sputum proteomics and airway cell transcripts of current and ex-smokers with severe asthma in U-BIOPRED: an exploratory analysis 67
Haemophilus influenzae and Moraxella catarrhalis in sputum of severe asthma with inflammasome and neutrophil activation 66
Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation 58
Stratification of asthma by lipidomic profiling of induced sputum supernatant 58
Totale 12.305
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.718
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.718
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022811 0 64 22 68 66 35 22 138 39 46 173 138
2022/20231.633 201 215 131 277 133 226 48 125 186 17 45 29
2023/2024815 34 248 17 113 26 104 56 10 7 39 64 97
2024/20251.555 32 50 124 54 121 39 57 54 237 159 352 276
2025/20264.630 713 167 267 456 797 256 915 194 240 304 130 191
2026/2027513 188 325 0 0 0 0 0 0 0 0 0 0
Totale 12.509